Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Genetic toxicity in vitro

Description of key information

Gene mutation toxicity study was performed by Errol Zeiger et al (Environmental and Molecular Mutagenesis, 1988) to determine the mutagenic nature of N-ethyl-N phenyl benzyl amine (92-59-1) using Salmonella typhimurium strains. In vitro genetic toxicity test for N-ethyl-N phenyl benzyl amine was performed on Salmonella typhimurium strains TA97, TA98, TA100, and TA1535 by Preincubation method. The test chemical (0.05 ml), Salmonella culture (0.10 ml), and S-9 mix or buffer (0.50 ml) was incubated at 37°C, without shaking, for 20 min. After that histidine-independent (his+) colonies were counted on plates by machine unless there was any precipitate was present which interfered with the count, or the colour of the test chemical on the plate reduced the contrast between the colonies and the background agar. The test material was exposed at the concentration of 0.000, 100.000, 333.000, 1000.000, 3333.000, 6666.000, 10000.000 µg/plate. There are some variations in protocol as the first test of a chemical was without activation and with 10% S-9 in the S-9 mix. If a positive result was obtained the test was repeated. If the tests were negative they were repeated without S-9 and with 30% S-9.Concurrent solvent and positive controls were run with each test. After exposure no mutagenic effect were observed. Therefore N-ethyl-N phenyl benzyl amine (92-59-1) was considered to be non mutagenic in Salmonella typhimurium strains TA97, TA98, TA100, and TA1535in the presence and absence of metabolic activation.

Link to relevant study records
Reference
Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment
Justification for type of information:
Data is from publication .
Qualifier:
according to guideline
Guideline:
other: As mentioned below
Principles of method if other than guideline:
To evaluate the mutagenic potential of N-Ethyl-N-phenyl benzyl amine in Salmonella typhimurium strains TA97, TA98, TA100, and TA1535 by Ames tests.
GLP compliance:
not specified
Type of assay:
bacterial reverse mutation assay
Specific details on test material used for the study:
- Name of test material: N-benzyl-N-ethylaniline
- Molecular formula: C15H17N
- Molecular weight : 211.306 g/mol
- Smiles notation: N(c1ccccc1)(Cc1ccccc1)CC
- InChl: 1S/C15H17N/c1-2-16(15-11-7-4-8-12-15)13-14-9-5-3-6-10-14/h3-12H,2,13H2,1H3
- Substance type: Organic
- Physical state: Liquid
Target gene:
Histidine
Species / strain / cell type:
S. typhimurium, other: TA97, TA98, TA100, TA1535
Details on mammalian cell type (if applicable):
Not applicable
Additional strain / cell type characteristics:
not specified
Cytokinesis block (if used):
Not specified .
Metabolic activation:
with and without
Metabolic activation system:
S-9 from Aroclor-induced male Sprague-Dawley rats and Syrian hamsters liver
Test concentrations with justification for top dose:
0.000,100.000,333.000,1000.000,3333.000,6666.000,10000.000 µg/plate
Vehicle / solvent:
DMSO(Dimethyl sulfoxide)
Untreated negative controls:
not specified
Negative solvent / vehicle controls:
yes
True negative controls:
not specified
Positive controls:
yes
Positive control substance:
other: Positive control in absence of metabolic activation: sodium azide (for strain TA1535 and TA100), 9-aminoacridine (TA97 and TA 1537), and 4-nitro-o-phenylenediamine (TA98). Positive control in presences of metabolic activation: 2-aminoanthracene
Details on test system and experimental conditions:
Details on test system and conditions
METHOD OF APPLICATION: Preincubation method

DURATION
- Preincubation period: 20 min
- Exposure duration: 2 days
- Expression time (cells in growth medium): 2 days
Rationale for test conditions:
Not specified
Evaluation criteria:
Number of histidine-independent (his+) colonies
Statistics:
Standard deviation was observed.
Key result
Species / strain:
S. typhimurium, other: TA97, TA98, TA100, TA1535
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
not specified
Vehicle controls validity:
valid
Untreated negative controls validity:
not specified
Positive controls validity:
valid
Additional information on results:
RANGE-FINDING/SCREENING STUDIES: Chemical was tested by their half life dose intervals up to doses that elicited toxicity, or to a dose immediately below one which was toxic in the preliminary toxicity test and subsequent dose increments and may not have included doses in the toxic range were used.

N-benzyl-N-ethylaniline Result for AMES test

Dose (µg/plate)

TA100

NA (-)

10% HLI (-)

10% RLI (-)

Mean

SEM

Mean

SEM

Mean

SEM

0.000

103

3.5

105

9.4

128

6.4

100

94

2.9

98

8.6

107

2.4

333

95

1.9

95

3.2

127

5.9

1000

96

4.3

92

5.2

115

8.4

3333

90P

3.5

88P

0.9

98P

1.5

6666

89P

2.8

 

 

 

 

10000

 

 

100P

1.7

110P

1.9

Positive control

601

12.4

2276

47.7

724

34.5

 

Dose (µg/plate)

TA100

NA (-)

30% HLI (-)

30% RLI (-)

Mean

SEM

Mean

SEM

Mean

SEM

0.000

103

3.5

99

1.9

120

10

100

94

2.9

114

7.0

130

13

333

95

1.9

105

9.3

126

7.3

1000

96

4.3

97

3.8

105

7.2

3333

90P

3.5

88P

1.0

95P

8.7

6666

89P

2.8

-

-

-

-

10000

 

 

93P

3.8

88P

6.1

Positive control

601

12.4

2067

38.7

761

7.3

 

Dose (µg/plate)

TA1535

NA (-)

10% HLI (-)

10% RLI (-)

Mean

SEM

Mean

SEM

Mean

SEM

0.000

9

1.8

9

1.7

12

0.9

100

11

1

6

0.9

8

1.2

333

12

2.8

5

2.0

10

1.2

1000

8

1.2

5

0.9

8

0.3

3333

5P

1.2

5P

2.2

5P

1.2

6666

4P

1

 

 

 

 

10000

 

 

5P

1.5

9P

0.3

Positive control

490

20.9

342

19.1

224

1.5

 

 

Dose (µg/plate)

TA1535

NA (-)

10% HLI (-)

10% RLI (-)

Mean

SEM

Mean

SEM

Mean

SEM

0.000

9

1.8

10

1.5

11

1.2

100

11

1

9

2.8

9

2.1

333

12

2.8

9

0.9

11

2.3

1000

8

1.2

8

1.7

9

0.6

3333

5P

1.2

9P

1.5

8P

1.7

6666

4P

1

 

 

 

 

10000

 

 

4P

0.6

9P

1.5

Positive control

490

20.9

361

25.9

198

12.5

 

Dose (µg/plate)

TA97

NA (-)

10% HLI (-)

10% RLI (-)

Mean

SEM

Mean

SEM

Mean

SEM

0.000

129

8.7

136

9.4

157

3.5

100

102

5.0

143

4.7

163

7.8

333

88

8.1

147

5.8

166

6.8

1000

84

3.2

135

6.5

142

2.5

3333

73P

7.8

135P

14.4

121P

4.9

6666

73P

7.8

 

 

 

 

10000

 

 

128P

10.2

134P

13.3

Positive control

1165

125.1

1440

66.5

1223

27.1

                                                                          

 

Dose (µg/plate)

TA97

NA (-)

30% HLI (-)

30% RLI (-)

Mean

SEM

Mean

SEM

Mean

SEM

0.000

129

8.7

188

6.6

187

10.1

100

102

5.0

181

16.6

187

2.0

333

88

8.1

175

10.7

180

12.4

1000

84

3.2

136

6.4

123

8.9

3333

73P

7.8

113P

5.8

134P

19.2

6666

73P

7.8

 

 

 

 

10000

 

 

112P

6.2

120P

5.3

Positive control

1165

125.1

500

3.2

1251

49.7

 

Dose (µg/plate)

TA98

NA (-)

10% HLI (-)

10% RLI (-)

Mean

SEM

Mean

SEM

Mean

SEM

0.000

13

2.3

27

1

30

2.8

100

13

0

30

2.7

32

0.9

333

12

2.3

22

2.1

30

1.5

1000

12

2

20

2.7

29

1.2

3333

13P

3.5

19P

1.2

25P

1.7

6666

8P

0.6

 

 

 

 

10000

 

 

22P

3.4

27P

2

Positive control

1115

88.9

1482

54.2

389

17.5

 

Dose (µg/plate)

TA98

NA (-)

30% HLI (-)

30% RLI (-)

Mean

SEM

Mean

SEM

Mean

SEM

0.000

13

2.3

19

2.1

19

0.9

100

13

0

24

2.6

32

0.6

333

12

2.3

25

4.3

19

1.2

1000

12

2

23

3.2

27

2.5

3333

13P

3.5

27P

3.5

20P

4.1

6666

8P

0.6

 

 

 

 

10000

 

 

18P

1.5

23P

3.5

Positive control

1115

88.9

1492

153.8

483

12.2

 

 

Conclusions:
The endpoint for the genetic toxicity in vitro of N-ethyl-N phenyl benzyl amine (92-59-1) was considered to be negative in the presence and absence of metabolic activator in Salmonella typhimurium strains TA97, TA98, TA100, and TA1535 by Preincubation method.
Executive summary:

In vitro genetic toxicity test for N-ethyl-N phenyl benzyl amine (92-59-1) was performed on Salmonella typhimurium strains TA97, TA98, TA100, and TA1535 by Preincubation method. The test chemical (0.05 ml), Salmonella culture (0.10 ml), and S-9 mix or buffer (0.50 ml) was incubated at 37°C, without shaking, for 20 min. After that histidine-independent (his+) colonies were counted on plates by machine unless there was any precipitate was present which interfered with the count, or the color of the test chemical on the plate reduced the contrast between the colonies and the background agar.The test material was exposed at the concentration of 0.000 ,100.000, 333.000, 1000.000,3333.000,6666.000,10000.000 µg/plate. There are some variations in protocol as the first test of a chemical was without activation and with 10% S-9 in the S-9 mix. If a positive result was obtained the test was repeated.If the tests were negative they were repeated without S-9 and with 30% S-9.Concurrent solvent and positive controls were run with each test. After exposure no mutagenic effect were observed.Therefore N-ethyl-N phenyl benzyl amine (92-59-1) was considered to be non mutagenic in Salmonella typhimurium strains TA97, TA98, TA100, and TA1535in the presence and absence of metabolic activation.

Hence it is not likely to be classified as genetic mutant in vitro.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (negative)

Genetic toxicity in vivo

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

Genotoxicity In-vitro

Various publications were reviewed to determine the mutagenic nature of N-ethyl-N phenyl benzyl amine (92-59-1). The studies are as mentioned below:

Gene mutation toxicity study was performed by Errol Zeiger et al (Environmental and Molecular Mutagenesis, 1988) to determine the mutagenic nature of N-ethyl-N phenyl benzyl amine (92-59-1) using Salmonella typhimurium strains. In vitro genetic toxicity test for N-ethyl-N phenyl benzyl amine was performed on Salmonella typhimurium strains TA97, TA98, TA100, and TA1535 by Preincubation method. The test chemical (0.05 ml), Salmonella culture (0.10 ml), and S-9 mix or buffer (0.50 ml) was incubated at 37°C, without shaking, for 20 min. After that histidine-independent (his+) colonies were counted on plates by machine unless there was any precipitate was present which interfered with the count, or the colour of the test chemical on the plate reduced the contrast between the colonies and the background agar. The test material was exposed at the concentration of 0.000, 100.000, 333.000, 1000.000, 3333.000, 6666.000, 10000.000 µg/plate. There are some variations in protocol as the first test of a chemical was without activation and with 10% S-9 in the S-9 mix. If a positive result was obtained the test was repeated. If the tests were negative they were repeated without S-9 and with 30% S-9.Concurrent solvent and positive controls were run with each test. After exposure no mutagenic effect were observed. Therefore N-ethyl-N phenyl benzyl amine (92-59-1) was considered to be non mutagenic in Salmonella typhimurium strains TA97, TA98, TA100, and TA1535in the presence and absence of metabolic activation.

Supported by a experimental study conducted by U.S. National Library of Medicine (CCRIS: N-ETHYL-N-PHENYLBENZYLAMINE, database by TOXNET toxicology data network, 2017), Gene mutation toxicity study in vitro was performed to determine the mutagenic nature of N-ethyl-N phenyl benzyl amine. In genetox study N-Ethyl-N-Phenylbenzylamine (92-59-1) was assessed for its possible mutagenic potential. For this purpose In vitro gene mutation study in bacteria was conducted on S. typhimurium strain TA98, TA100, TA 1535, TA 1537, TA 1538and E.coli WP2UVRA by using preincubation method . DMSO was used as a solvent .The test material was used at concentration of 0, 20-5000 µg/Plate in the presence and absence of metabolic activation. No significant mutagenic effects were observed for N-Ethyl-N-Phenylbenzylaminein the presence and absence of metabolic activator. Therefore N-Ethyl-N-Phenylbenzylamine (92-59-1) was considered to be non mutagenic with and without metabolic activator in S. typhimurium strain TA98, TA100, TA 1535, TA 1537, TA 1538and E.coli WP2UVRA by Ames test. Therefore it is not likely to be classifying as gene mutant in vitro.

It is further supported by prediction data on N-benzyl-N-ethylaniline. Gene mutation toxicity was predicted for N-benzyl-N-ethylaniline (92-59-1) using the battery approach from Danish QSAR database (2017). The study assumed the use of Salmonella typhimurium bacteria in the Ames test. The end point for gene mutation has been modeled in the Danish QSAR using the three software systems Leadscope, CASE Ultra and SciQSAR. Based on predictions from these three systems, a fourth and overall battery prediction is made. The battery prediction is made using the so called Battery algorithm. With the battery approach it is in many cases possible to reduce “noise” from the individual model estimates and thereby improve accuracy and/or broaden the applicability domain.Gene mutation toxicity study as predicted by Danish QSAR for N-benzyl-N-ethylaniline (92-59-1) is negative and hence the chemical is predicted to not classify as a gene mutant in vitro

 

Based on the data and prediction, available for the target chemical, N-benzyl-N-ethylaniline (92-59-1) does not induce gene mutation in vitro. Hence the test chemical is not likely to classify as a gene mutant in vitro.

Justification for classification or non-classification

Thus based on the above annotation and CLP criteria , the target chemical, N-benzyl-N-ethylaniline (92-59-1) is not likely to classify as a gene mutant in vitro.